文献速递消化道肿瘤与早癌消化内镜

采用年度粪便免疫化学检测的有组织结直肠癌筛查项目的组成与结果

Program Components and Results From an Organized Colorectal Cancer Screening Program Using Annual Fecal Immunochemical Testing.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-09-30

在凯撒永久北加州综合卫生系统2017年51-75岁人群中,对1,023,415名符合筛查条件者实施邮寄粪便免疫化学检测(FIT)联合机会性结肠镜检查。项目通过邮寄FIT、自动提醒、个人联系等多种方式,使累计839,463人(82%)在年末达到筛查最新状态,阳性FIT者诊断性结肠镜检查完成率为83.7%。

要点

  • 基线时40%符合条件者筛查状态已达标,对未达标者邮寄FIT后20%在28天内完成。
  • 第4周自动语音电话后额外6%完成FIT,第6周邮寄提醒信后额外4%完成。
  • 年末累计82%符合条件者筛查达标,阳性FIT者结肠镜检查完成率83.7%。

核心结论

  • 该项目的筛查参与率超过82%,归因于既往内镜检查(40%)、邮寄FIT的初始大幅应答(20%)、随后对自动提醒的较小应答(10%)和个人联系(12%)的综合作用。

研究设计与样本

  • 混合方法研究,包含现场访视和对2017年凯撒永久北加州综合卫生系统51-75岁成人的回顾性队列分析。

主要发现

  • 在1,023,415名符合筛查条件者中,405,963人(40%)基线时筛查状态已达标,617,452名未达标者中507,401人收到邮寄FIT试剂盒。
  • 全队列中206,481人(20%)在邮寄后28天内完成FIT,另61,644人(6%)在第4周自动语音电话后完成,另40,438人(4%)在第6周邮寄提醒信后完成。
  • 111,377人(11%)在自动外展期之外完成FIT,另13,560人(1.3%)完成了与FIT无关的结肠镜检查、乙状结肠镜检查或粪便潜血试验。
  • 年末累计839,463人(82%)符合条件者筛查达标,14,450例FIT阳性患者中12,091例(83.7%)接受了诊断性结肠镜检查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Programmatic colorectal cancer (CRC) screening increases uptake, but the design and resources utilized for such models are not well known. We characterized program components and participation at each step in a large program that used mailed fecal immunochemical testing (FIT) with opportunistic colonoscopy. METHODS: Mixed-methods with site visits and retrospective cohort analysis of 51-75-year-old adults during 2017 in the Kaiser Permanente Northern California integrated health system. RESULTS: Among 1,023,415 screening-eligible individuals, 405,963 (40%) were up to date with screening at baseline, and 507,401 of the 617,452 not up-to-date were mailed a FIT kit. Of the entire cohort (n = 1,023,415), 206,481 (20%) completed FIT within 28 days of mailing, another 61,644 (6%) after a robocall at week 4, and 40,438 others (4%) after a mailed reminder letter at week 6. There were over 800,000 medical record screening alerts generated and about 295,000 FIT kits distributed during patient office visits. About 100,000 FIT kits were ordered during direct-to-patient calls by medical assistants and 111,377 people (11%) completed FIT outside of the automated outreach period. Another 13,560 (1.3%) completed a colonoscopy, sigmoidoscopy, or fecal occult blood test unrelated to FIT. Cumulatively, 839,463 (82%) of those eligible were up to date with screening at the end of the year and 12,091 of 14,450 patients (83.7%) with positive FIT had diagnostic colonoscopy. CONCLUSIONS: The >82% screening participation achieved in this program resulted from a combination of prior endoscopy (40%), large initial response to mailed FIT kits (20%), followed by smaller responses to automated reminders (10%) and personal contact (12%).

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Selby K, Jensen CD, Levin TR, et al. Program Components and Results From an Organized Colorectal Cancer Screening Program Using Annual Fecal Immunochemical Testing. Clin Gastroenterol Hepatol. 2020. PMID: 33010408. doi:10.1016/j.cgh.2020.09.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。